Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113 Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Esophageal Neoplasms

abstract

  • Both arms of RTOG 0113 were associated with high morbidity, and the study did not meet its 1-year survival end point.

publication date

  • October 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2653130

Digital Object Identifier (DOI)

  • 10.1200/JCO.2008.16.6918

PubMed ID

  • 18574157

Additional Document Info

start page

  • 4551

end page

  • 6

volume

  • 26

number

  • 28